AAA Surgery Outcomes Improve

Medical News: Survival Improves for Abdominal Aortic Aneurysm Surgery – in Surgery, Thoracic Surgery from MedPage Today

Patients with AAA who were operated on from 2000 to 2005 had 4.7% higher relative five-year survival rates compared with patients whose surgery took place between 1987 and 1999 (99% CI 1.3 to 8.1), according to the study published June 6 in Circulation, the Journal of the American Heart Association.

Lipoprotein-Associated Phospholipase A2

Lipoprotein-Associated Phospholipase A2 a Novel Risk Marker

Hey Hank!  Give us a speech on this biomarker!

Oops! Missed Another One

Medical News: Abdominal Aortic Aneurysms Often Missed on CT Scans – in Radiology, Diagnostic Radiology from MedPage Today

Moreover, 9% of aneurysms unidentified were 5.5 cm or larger, and clinical teams didn’t recognize 58% of dilations within three months of the scan.

Oops.

Know Your Receptor Status in Breast Cancer Risks

Medical News: Receptor Status Drives Contralateral Breast Cancer Risk – in Oncology, Breast Cancer from MedPage Today

Scary Chart of the Day – July 11, 2009

Having fun with numbers.

EconomPic: The “Exhaustion Rate” Underestimates the Issue

Read this blog article to gain a deeper understanding of how bad things really are.

Lincoln Update – July 10, 2009

Lincoln Injects Cash Into Life Unit After Taking TARP (Update3) – Bloomberg.com

Scary Chart of the Day – July 10, 2009

Does it look like the numbers are trending down or staying steady?

NPR: Why You Can’t Trust The New Job-Loss Numbers

Cheese Fries, No Chili Please. I’m Cutting Back

Medical News: Low-Calorie Diet May be Fountain of Youth – in Geriatrics, General Geriatrics from MedPage Today

Coming soon to your teleunderwriting operation – the CCDDQ.

(Calories Consumed Drill Down Questionnaire)

5th Annual Cow Appreciation Day – July 10, 2009

Chick-fil-A Cow Appreciation Day

Dress like a cow.  Get free food.

Alimta – Think Strong Stuff for a Bad Disease

Alimta Approved as Maintenance Therapy for Advanced Lung Cancer – US News and World Report

The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.